MANE

119.5203.92%
PG

Patrick Gerald Enright

Independent Director

Mr. Patrick Gerald Enright, MBA, is Independent Non-Employee Director of Veradermics, Incorporated from December 2024. Mr. Enright serves as Co-Founder, MD & Managing Member at Longitude Capital Management Co. LLC. He joined the Longitude Capital Management Co. LLC in 2006. He focuses on Biotechnology and Health Solutions. He is Chair of the Board at CuraSen Therapeutics, Inc since October 2024. He is Independent Director of BioAge Labs, Inc. since February 2024. He serves as a Director of VeraDermics, Inc. He is Independent Director of Jazz Pharmaceuticals plc from July 2009. He joined the Jazz Pharmaceuticals plc on July 01, 2009. He is Director of Epirium Bio, Inc. He is Director of Orbus Therapeutics, Inc. from August 2015. He joined the Orbus Therapeutics, Inc. in August 2015. Mr. Enright was a Managing Director of Pequot Ventures, where he co-led the life sciences investment practice. Mr. Enright also has significant life sciences operations experience, including senior executive positions at Valentis (VLTS), Hoffman – La Roche and Novartis. He was Lead Independent Director of Aptinyx Inc. from January 01, 2022 to November 30, 2022. He joined the Aptinyx Inc. on May 10, 2016. He was Independent Chairman of the Board of Aptinyx Inc. from May 20, 2020 to January 1, 2022. He was Independent Director of Aptinyx Inc. from May 10, 2016 to May 20, 2020. He is Director of CuraSen Therapeutics, Inc. from October 17, 2018. He is Director of Dascena, Inc. He is Director of Endeavor BioMedicines, Inc. He is Independent Director of Vera Therapeutics, Inc. from October 2020. He serves as Director of Zenas BioPharma Limited. He was Director of Rivus Pharmaceuticals, Inc. until 2024. He serves as an Independent Director of Zena BioPharma, Inc. and served as Director since November 2022. He was Director of Valentis Inc. He joined the Valentis Inc. in March 1998. He was Executive Officer of Novartis AG. He was Managing Director of FirstMark Capital, L.L.C. He focused on Healthcare. He was Director of Sequenom Inc. He was employed at Sequenom Inc. from June 2006 to July 11, 2007. He was Director of NuGEN Technologies, Inc. He was Director of Threshold Pharmaceuticals, Inc. He was employed at Threshold Pharmaceuticals, Inc. from 2003 to April 02, 2007. He was Director of Corcept Therapeutics Incorporated. He joined the Corcept Therapeutics Incorporated on April 01, 2008. He was Director of Esperion Therapeutics, Inc. He was employed at Esperion Therapeutics, Inc. from April 25, 2013 to June 09, 2016. He was Independent Director of Aimmune Therapeutics, Inc. from April 2013 to October 13, 2020. He was employed at Aimmune Therapeutics, Inc. from April 2013 to October 13, 2020. He was Director of Horizon Therapeutics plc. He was Director - Megabios of GeneMedicine, Inc. He joined the GeneMedicine, Inc. in March 1998. He was Director of Codexis, Inc. He was Director of Raven Biotechnologies, Inc. He was Director of Xanodyne Pharmaceuticals, Inc. He was Director of InfaCare Pharmaceutical Corporation. He was Senior Vice President of Roche Diagnostics GmbH. He was Director of Intuity Medical, Inc. He was Director of Prestwick Pharmaceuticals, Inc. He joined the Prestwick Pharmaceuticals, Inc. in November 2004. He was Director of MAP Pharmaceuticals, Inc. He was Director of DiObex, Inc. He was Director of Azur Pharma Public Limited Company. He was Director of CardioDx, Inc. from February 2011. He joined the CardioDx, Inc. in February 2011. He was Director of Urigen Pharmaceuticals, Inc. He was Independent Director of Vaxcyte, Inc. from July 23, 2015. He joined the Vaxcyte, Inc. on July 23, 2015. He was Investment Professional of PaineWebber Development Corporation. He was Managing Partner of Diaz & Altschul Group LLC. He is director at Opna Bio. He was Director at National Venture Capital Association. He has B.S. in Biological Sciences from Stanford University, M.B.A. from University of Pennsylvania - The Wharton School.

Positions